天美生物宣布签署价值1800万美元的合作协议,将共同开发创新的第二代苹果系列健康产品。
天美生物宣布签署价值1800万美元的合作协议,将共同开发创新的第二代苹果系列健康产品。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.